Cornerstone Capital, Inc. Bristol Myers Squibb CO Transaction History

Cornerstone Capital, Inc.

$920 Million
Q1 2025

A detailed history of Cornerstone Capital, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cornerstone Capital, Inc. holds 8,985 shares of BMY stock, worth $420,048. This represents 0.06% of its overall portfolio holdings.

Number of Shares

8,985

Previous 9,444 4.86%

Holding current value

$420,048

Previous $534,000 2.43%

% of portfolio

0.06%

Previous 0.06%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$53.9 - $63.11 $24,740 - $28,967	-459 Reduced 4.86%	8,985 $547,000
Q3 2024 Oct 30, 2024	BUY	$39.66 - $51.75 $18,203 - $23,753	459 Added 5.11%	9,444 $488,000
Q2 2024 Aug 02, 2024	BUY	$40.25 - $52.99 $100,625 - $132,475	2,500 Added 38.55%	8,985 $373,000
Q1 2024 May 01, 2024	SELL	$47.98 - $54.4 $95,960 - $108,800	-2,000 Reduced 23.57%	6,485 $351,000
Q2 2023 Aug 21, 2023	BUY	$63.71 - $70.74 $6,371 - $7,073	100 Added 1.19%	8,485 $542,000
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $7,556 - $8,570	-115 Reduced 1.35%	8,385 $581,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $65,056 - $77,035	-950 Reduced 10.05%	8,500 $611,000
Q3 2022 Oct 27, 2022	BUY	$0.13 - $76.84 $26 - $15,368	200 Added 2.16%	9,450 $672,000
Q4 2021 Feb 11, 2022	SELL	$53.63 - $62.52 $278,339 - $324,478	-5,190 Reduced 35.94%	9,250 $577,000
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $5,934 - $6,673	-100 Reduced 0.69%	14,440 $912,000
Q4 2020 Feb 12, 2021	BUY	$57.74 - $65.43 $195,161 - $221,153	3,380 Added 30.29%	14,540 $902,000
Q3 2020 Oct 27, 2020	SELL	$57.43 - $63.64 $3,732 - $4,136	-65 Reduced 0.58%	11,160 $673,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $9,045 - $10,574	165 Added 1.49%	11,225 $660,000
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $29,696 - $43,155	-640 Reduced 5.47%	11,060 $616,000
Q3 2019 Nov 13, 2019	SELL	$42.77 - $50.71 $2.44 Million - $2.89 Million	-56,986 Reduced 82.97%	11,700 $593,000
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $2.72 Million - $3 Million	60,890 Added 781.04%	68,686 $3.12 Million
Q1 2019 May 15, 2019	SELL	$45.12 - $53.8 $4.34 Million - $5.17 Million	-96,140 Reduced 92.5%	7,796 $3.68 Million
Q4 2018 Feb 11, 2019	SELL	$48.76 - $63.23 $125,020 - $162,121	-2,564 Reduced 2.41%	103,936 $5.4 Million
Q3 2018 Nov 13, 2018	BUY	$55.19 - $62.25 $8,554 - $9,648	155 Added 0.15%	106,500 $6.61 Million
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $13,895 - $17,319	-275 Reduced 0.26%	106,345 $5.89 Million
Q1 2018 May 08, 2018	BUY	$59.92 - $68.98 $11,384 - $13,106	190 Added 0.18%	106,620 $6.74 Million
Q4 2017 Feb 12, 2018	SELL	$59.94 - $65.35 $88,411 - $96,391	-1,475 Reduced 1.37%	106,430 $6.52 Million
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $5.96 Million - $6.88 Million	107,905	107,905 $6.88 Million

Others Institutions Holding BMY

# of Institutions

2,801

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $99.4B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Capital, Inc. with notifications on news.

Account

Cornerstone Capital, Inc. Bristol Myers Squibb CO Transaction History